摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-methoxyphenyl)-3,5-dimethoxybenzamide | 134029-83-7

中文名称
——
中文别名
——
英文名称
N-(4-methoxyphenyl)-3,5-dimethoxybenzamide
英文别名
N-(p-methoxyphenyl)-3,5-dimethoxybenzamide;3,5-Dimethoxy-N-(4-Methoxyphenyl)Benzamide
N-(4-methoxyphenyl)-3,5-dimethoxybenzamide化学式
CAS
134029-83-7
化学式
C16H17NO4
mdl
MFCD00754697
分子量
287.315
InChiKey
NGIDRYCBDLWOSR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    384.7±42.0 °C(Predicted)
  • 密度:
    1.195±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    56.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(4-methoxyphenyl)-3,5-dimethoxybenzamide 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 4.0h, 生成 N-(3,5-dimethoxybenzyl)-4-methoxybenzenamine
    参考文献:
    名称:
    Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization
    摘要:
    An array of cis-, trans-, and dihydrostilbenes and some N-arylbenzylamines were synthesized and evaluated for their cytotoxicity in the five cancer cell cultures A-549 lung carcinoma, MCF-7 breast carcinoma, HT-29 colon adenocarcinoma, SKMEL-5 melanoma, and MLM melanoma. Several cis-stilbenes, structurally similar to combretastatins, were highly cytotoxic in all five cell lines and these were also found to be active as inhibitors of tubulin polymerization. The most active compounds also inhibited the binding of colchicine to tubulin. The most potent of the new compounds, both as a tubulin polymerization inhibitor and as a cytotoxic agent, was (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (5a). This substance was almost as potent as combretastatin A-4 (1a), the most active of the combretastatins, as a tubulin polymerization inhibitor. Compound 5a was found to be approximately 140 times more cytotoxic against HT-29 colon adenocarcinoma cells and about 10 times more cytotoxic against MCF-7 breast carcinoma cells than combretastatin A-4. However, 5a was found to be about 20 times less cytotoxic against A-549 lung carcinoma cells, 30 times less cytotoxic against SKMEL-5 melanoma cells, and 7 times less cytotoxic against MLM melanoma cells than combretastatin A-4. The relative potencies 5a > 8a > 6a for the cis, dihydro, and trans compounds, respectively, as inhibitors of tubulin polymerization are in agreement with the relative potencies previously observed for combretastatin A-4 (1a), dihydrocombretastatin A-4 (1c), and trans-combretastatin A-4 (1b). The relative potencies 5a > 8a > 6a were also reflected in the results of the cytotoxicity assays. Structure-activity relationships of this group of compounds are also discussed.
    DOI:
    10.1021/jm00112a036
  • 作为产物:
    描述:
    甲氧苯胺3,5-二甲氧基苯甲酸三氯乙腈三苯基膦 作用下, 以 二氯甲烷 为溶剂, 反应 16.0h, 以56.2%的产率得到N-(4-methoxyphenyl)-3,5-dimethoxybenzamide
    参考文献:
    名称:
    白藜芦醇衍生物对前列腺癌细胞进展的有效抑制作用
    摘要:
    在各种研究中,白藜芦醇已被确定为一种有效的抗癌剂。在这项研究中,合成并研究了几种白藜芦醇衍生物,以寻找比白藜芦醇更有效的抗癌剂。在我们对癌细胞系的检查期间,化合物 C、F 和 G 在 PC-3 和 LNCaP 人前列腺癌细胞的生长方面表现出比白藜芦醇更高的抑制活性。此外,白藜芦醇的四种衍生物在 LNCaP 细胞中显示出有效的生长抑制活性 (IC50 0.01 ~ 0.04 μM)。这些衍生物的活性水平是与白藜芦醇相关的活性水平的 25-100 倍(IC50 1.0 μM)。我们的结果表明,化合物 C、D、F 和 G 可能作为前列腺肿瘤的抗癌剂发挥作用。
    DOI:
    10.1002/ardp.200500228
点击查看最新优质反应信息

文献信息

  • Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties
    作者:Simone Bertini、Vincenzo Calderone、Isabella Carboni、Roberta Maffei、Alma Martelli、Adriano Martinelli、Filippo Minutolo、Mehdi Rajabi、Lara Testai、Tiziano Tuccinardi、Riccardo Ghidoni、Marco Macchia
    DOI:10.1016/j.bmc.2010.07.059
    日期:2010.9
    New resveratrol (RES) analogs were developed by replacing the aromatic ‘core’ of our initial naphthalene-based RES analogs with pseudo-heterocyclic (salicylaldoxime) or heterocyclic (benzofuran, quinoline, and benzothiazole) scaffolds. The resulting analogs were tested for their antiproliferative and vasorelaxing effect, two typical properties shown by RES. Some of the new compounds confirmed strong
    通过用假杂环(水杨醛肟)或杂环(苯并呋喃,喹啉和苯并噻唑)支架取代我们最初的萘基RES类似物的芳族“核心”,开发了新的白藜芦醇(RES)类似物。测试了所得类似物的抗增殖和血管松弛作用,这是RES显示的两个典型特性。一些新化合物证实了很强的抗增殖活性,可与以前以最具活性的萘基类似物发现的抗坏血酸相媲美。特别地,3-(3,5-二羟基苯基)-7-羟基喹啉表现出最有效的抗增殖作用(IC 50  = 17.4μM)。在血管测定中,最高效力(pIC 50  = 4.92)和功效(E max 用2-(3,5-二羟基苯基)-6-羟基苯并噻唑获得=(88.2%)。这些化合物的构象分析表明,对MDA-MB-231癌细胞的抗增殖活性可能与活性最高的化合物的共同空间分布有关,尤其是与三个酚基的空间排列有关。此外,血管松弛性质与通过静电分子电势(ESP)测得的电子性质具有良好的相关性。
  • Nickel-catalyzed C–H/N–H annulation of aromatic amides with alkynes in the absence of a specific chelation system
    作者:Atsushi Obata、Yusuke Ano、Naoto Chatani
    DOI:10.1039/c7sc01750b
    日期:——
    of KOBut involves C–H/N–H oxidative annulation to give 1(2H)-isoquinolinones. A key to the success of the reaction is the use of a catalytic amount of strong base, such as KOBut. The reaction shows a high functional group compatibility. The reaction with unsymmetrical alkynes, such as 1-arylalkynes, gives the corresponding 1(2H)-isoquinolinones with a high level of regioselectivity. This discovery would
    具有在甲部存在炔芳族酰胺的Ni基催化的反应吨涉及C-H / N-H的氧化环,得到1-(2 ħ)异喹啉酮。反应成功的关键是使用催化量的强碱,例如KOBu t。该反应显示出高的官能团相容性。与不对称炔烃,例如1-芳基炔烃的反应,得到具有高区域选择性的相应的1(2 H)-异喹啉酮。这一发现将导致开发镍催化的螯合辅助的C–H功能化反应,而无需特定的螯合系统。
  • Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization
    作者:Mark Cushman、Dhanapalan Nagarathnam、D. Gopal、Asit K. Chakraborti、Chii M. Lin、Ernest Hamel
    DOI:10.1021/jm00112a036
    日期:1991.8
    An array of cis-, trans-, and dihydrostilbenes and some N-arylbenzylamines were synthesized and evaluated for their cytotoxicity in the five cancer cell cultures A-549 lung carcinoma, MCF-7 breast carcinoma, HT-29 colon adenocarcinoma, SKMEL-5 melanoma, and MLM melanoma. Several cis-stilbenes, structurally similar to combretastatins, were highly cytotoxic in all five cell lines and these were also found to be active as inhibitors of tubulin polymerization. The most active compounds also inhibited the binding of colchicine to tubulin. The most potent of the new compounds, both as a tubulin polymerization inhibitor and as a cytotoxic agent, was (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene (5a). This substance was almost as potent as combretastatin A-4 (1a), the most active of the combretastatins, as a tubulin polymerization inhibitor. Compound 5a was found to be approximately 140 times more cytotoxic against HT-29 colon adenocarcinoma cells and about 10 times more cytotoxic against MCF-7 breast carcinoma cells than combretastatin A-4. However, 5a was found to be about 20 times less cytotoxic against A-549 lung carcinoma cells, 30 times less cytotoxic against SKMEL-5 melanoma cells, and 7 times less cytotoxic against MLM melanoma cells than combretastatin A-4. The relative potencies 5a > 8a > 6a for the cis, dihydro, and trans compounds, respectively, as inhibitors of tubulin polymerization are in agreement with the relative potencies previously observed for combretastatin A-4 (1a), dihydrocombretastatin A-4 (1c), and trans-combretastatin A-4 (1b). The relative potencies 5a > 8a > 6a were also reflected in the results of the cytotoxicity assays. Structure-activity relationships of this group of compounds are also discussed.
  • Potent Inhibitory Effects of Resveratrol Derivatives on Progression of Prostate Cancer Cells
    作者:Kyung Mi Yoo、Sanghee Kim、Bo Kyung Moon、Sung Soo Kim、Kyung Tack Kim、Sun Yeou Kim、Sang Yoon Choi
    DOI:10.1002/ardp.200500228
    日期:2006.5
    and LNCaP human prostate cancer cells. Moreover, four derivatives of resveratrol evidenced potent growth inhibitory activity (IC50 0.01 ˜ 0.04 μM) in LNCaP cells. The levels of activity in these derivatives were 25 ˜ 100 times stronger than that associated with resveratrol (IC50 1.0 μM). Our results suggested that compounds C, D, F, and G might function as anticancer agents on prostate tumors. This study
    在各种研究中,白藜芦醇已被确定为一种有效的抗癌剂。在这项研究中,合成并研究了几种白藜芦醇衍生物,以寻找比白藜芦醇更有效的抗癌剂。在我们对癌细胞系的检查期间,化合物 C、F 和 G 在 PC-3 和 LNCaP 人前列腺癌细胞的生长方面表现出比白藜芦醇更高的抑制活性。此外,白藜芦醇的四种衍生物在 LNCaP 细胞中显示出有效的生长抑制活性 (IC50 0.01 ~ 0.04 μM)。这些衍生物的活性水平是与白藜芦醇相关的活性水平的 25-100 倍(IC50 1.0 μM)。我们的结果表明,化合物 C、D、F 和 G 可能作为前列腺肿瘤的抗癌剂发挥作用。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐